HOKKAIDO UNIVERSITY OF JAPAN

US starts trial to evaluate antiviral in adults hospitalised with COVID

The therapeutic, known as S-217622 or ensitrelvir fumaric acid, was discovered by Hokkaido University of Japan; and Shionogi & Co., Ltd., a Japanese pharmaceutical company.